ProShares Ultra Bloomberg Natural Gas

United States Natural Gas

GraniteShares 1.5x Short NVDA Daily ETF

Direxion Daily FTSE China Bull 3X ETF

Direxion Daily 20+ Yr Trsy Bear 3X ETF

Direxion Daily Semicondct Bear 3X ETF

Direxion Technology Bear 3X Shares

Bank Of Montreal

Direxion Daily TSLA Bull 1.5X Shares

ProShares UltraShort Bloomberg Natrl Gas

Direxion Daily 20+ Yr Trsy Bull 3X ETF

GraniteShares 1.5x Long NVDA Daily ETF

Direxion Daily Semicondct Bull 3X ETF

ProShares Ultra Semiconductors

iShares Ethereum Trust ETF

Direxion Daily Technology Bull 3X ETF

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

ProShares UltraPro QQQ

Siyata Mobile Inc. Common Shares

Edible Garden AG Incorporated Common Stock

Eyenovia Inc. Common Stock

LOBO EV TECHNOLOGIES LTD. Ordinary shares

D-Wave Quantum Inc. Common Shares

Mind Medicine (MindMed) Inc. Common Shares

COMPASS Pathways Plc American Depository Shares

ScanTech AI Systems Inc. Common stock

Pony AI Inc. American Depositary Shares

Click Holdings Limited Ordinary Share

NWTN Inc. Class B Ordinary Shares

Protagenic Therapeutics Inc. Common Stock

Incannex Healthcare Limited American Depositary Shares

Brainstorm Cell Therapeutics Inc. Common Stock

ASP Isotopes Inc. Common Stock

Canaan Inc. American Depositary Shares

CoreWeave Inc. Class A Common Stock

Trip.com Group Limited American Depositary Shares

Freight Technologies Inc. Ordinary Shares

Eagle Materials Inc Common Stock

Click here to get full coverage on Why Chimerix Inc. (CMRX) is Surging in 2025 - Yahoo Finance

Why Chimerix Inc. (CMRX) is Surging in 2025  Yahoo Finance

Why Chimerix Inc. (CMRX) is Surging in 2025 - Yahoo Finance

Click here to get full coverage on CMRX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Chimerix, Inc. is Fair to Shareholders - GlobeNewswire

CMRX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Chimerix, Inc. is Fair to Shareholders  GlobeNewswire

CMRX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Chimerix, Inc. is Fair to Shareholders - GlobeNewswire

Click here to get full coverage on Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews

Pre-market Movers: CMRX, CPIX, PBM, CRVO...  RTTNews

Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews

Click here to get full coverage on Jazz To Buy Chimerix For $935 Mln To Boost Oncology Portfolio, CMRX Up In Pre-Market - Nasdaq

Jazz To Buy Chimerix For $935 Mln To Boost Oncology Portfolio, CMRX Up In Pre-Market  Nasdaq

Jazz To Buy Chimerix For $935 Mln To Boost Oncology Portfolio, CMRX Up In Pre-Market - Nasdaq

Click here to get full coverage on CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRX - Business Wire

CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRX  Business Wire

CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRX - Business Wire

Click here to get full coverage on Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025? - Yahoo Finance

Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025?  Yahoo Finance

Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025? - Yahoo Finance

Click here to get full coverage on Jazz Pharma Pays 72% Premium for Chimerix: Is This Rare Disease Drug Worth $935M? - Stock Titan

Jazz Pharma Pays 72% Premium for Chimerix: Is This Rare Disease Drug Worth $935M?  Stock Titan

Jazz Pharma Pays 72% Premium for Chimerix: Is This Rare Disease Drug Worth $935M? - Stock Titan

Click here to get full coverage on JAZZ (JAZZ) to Acquire Chimerix (CMRX) for $8.55/sh Cash - StreetInsider

JAZZ (JAZZ) to Acquire Chimerix (CMRX) for $8.55/sh Cash  StreetInsider

JAZZ (JAZZ) to Acquire Chimerix (CMRX) for $8.55/sh Cash - StreetInsider

Click here to get full coverage on Here's Why Momentum in Chimerix (CMRX) Should Keep going - Nasdaq

Here's Why Momentum in Chimerix (CMRX) Should Keep going  Nasdaq

Here's Why Momentum in Chimerix (CMRX) Should Keep going - Nasdaq

Click here to get full coverage on Revolutionary Brain Cancer Drug Gets Fast-Track to FDA Approval: Chimerix's Hope for Untreatable Glioma - Stock Titan

Revolutionary Brain Cancer Drug Gets Fast-Track to FDA Approval: Chimerix's Hope for Untreatable Glioma  Stock Titan

Revolutionary Brain Cancer Drug Gets Fast-Track to FDA Approval: Chimerix's Hope for Untreatable Glioma - Stock Titan

Click here to get full coverage on SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX, IVAC, BRDG on Behalf of Shareholders - GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX, IVAC, BRDG on Behalf of Shareholders  GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX, IVAC, BRDG on Behalf of Shareholders - GlobeNewswire

Click here to get full coverage on Why Chimerix, Inc. (CMRX) Soared Last Week - Yahoo Finance

Why Chimerix, Inc. (CMRX) Soared Last Week  Yahoo Finance

Why Chimerix, Inc. (CMRX) Soared Last Week - Yahoo Finance

Click here to get full coverage on Chimerix Leadership Reveals Future Growth Strategy at Elite Healthcare Conference - Stock Titan

Chimerix Leadership Reveals Future Growth Strategy at Elite Healthcare Conference  Stock Titan

Chimerix Leadership Reveals Future Growth Strategy at Elite Healthcare Conference - Stock Titan

Click here to get full coverage on Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025 - Yahoo Finance

Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025  Yahoo Finance

Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025 - Yahoo Finance

Click here to get full coverage on Here’s Why Chimerix, Inc. (CMRX) Is Skyrocketing - Yahoo Finance

Here’s Why Chimerix, Inc. (CMRX) Is Skyrocketing  Yahoo Finance

Here’s Why Chimerix, Inc. (CMRX) Is Skyrocketing - Yahoo Finance

Click here to get full coverage on Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More - Yahoo Finance

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More  Yahoo Finance

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More - Yahoo Finance

Click here to get full coverage on CMRX Stock Skyrockets in 3 Months: Here's What You Should Know - Yahoo Finance

CMRX Stock Skyrockets in 3 Months: Here's What You Should Know  Yahoo Finance

CMRX Stock Skyrockets in 3 Months: Here's What You Should Know - Yahoo Finance

Click here to get full coverage on Chimerix Inc (CMRX) Q3 2024 Earnings Call Highlights: Strategic Advancements Amid Financial ... - Yahoo Finance

Chimerix Inc (CMRX) Q3 2024 Earnings Call Highlights: Strategic Advancements Amid Financial ...  Yahoo Finance

Chimerix Inc (CMRX) Q3 2024 Earnings Call Highlights: Strategic Advancements Amid Financial ... - Yahoo Finance

Click here to get full coverage on Insider Move: Chimerix Grants 270,000 Share Options Package to Critical New Hires - Stock Titan

Insider Move: Chimerix Grants 270,000 Share Options Package to Critical New Hires  Stock Titan

Insider Move: Chimerix Grants 270,000 Share Options Package to Critical New Hires - Stock Titan

Click here to get full coverage on Chimerix to File FDA Application for Breakthrough Brain Cancer Drug with 28% Response Rate - Stock Titan

Chimerix to File FDA Application for Breakthrough Brain Cancer Drug with 28% Response Rate  Stock Titan

Chimerix to File FDA Application for Breakthrough Brain Cancer Drug with 28% Response Rate - Stock Titan

Click here to get full coverage on BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of  GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Click here to get full coverage on Chimerix: Potential 'First' In Targeting Recurrent High-Grade Glioma Patients (CMRX) - Seeking Alpha

Chimerix: Potential 'First' In Targeting Recurrent High-Grade Glioma Patients (CMRX)  Seeking Alpha

Chimerix: Potential 'First' In Targeting Recurrent High-Grade Glioma Patients (CMRX) - Seeking Alpha

Click here to get full coverage on Kuehn Law Encourages BRDG, CMRX, WBA and SYTA Investors to Contact Law Firm - PR Newswire

Kuehn Law Encourages BRDG, CMRX, WBA and SYTA Investors to Contact Law Firm  PR Newswire

Kuehn Law Encourages BRDG, CMRX, WBA and SYTA Investors to Contact Law Firm - PR Newswire

Click here to get full coverage on Jazz Pharmaceuticals to buy Chimerix for $935 million - Reuters

Jazz Pharmaceuticals to buy Chimerix for $935 million  Reuters

Jazz Pharmaceuticals to buy Chimerix for $935 million - Reuters

Click here to get full coverage on Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday? - Yahoo Finance

Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday?  Yahoo Finance

Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday? - Yahoo Finance

Click here to get full coverage on Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio - Yahoo Finance

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio  Yahoo Finance

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio - Yahoo Finance

Click here to get full coverage on JAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell? - TradingView

JAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell?  TradingView

JAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell? - TradingView

Click here to get full coverage on $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Chimerix, Inc. - CMRX - PR Newswire

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Chimerix, Inc. - CMRX  PR Newswire

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Chimerix, Inc. - CMRX - PR Newswire

Click here to get full coverage on Chimerix stock soars to 52-week high, hits $8.53 - Investing.com

Chimerix stock soars to 52-week high, hits $8.53  Investing.com

Chimerix stock soars to 52-week high, hits $8.53 - Investing.com

Click here to get full coverage on Chimerix downgraded to Neutral from Buy at H.C. Wainwright - Yahoo Finance

Chimerix downgraded to Neutral from Buy at H.C. Wainwright  Yahoo Finance

Chimerix downgraded to Neutral from Buy at H.C. Wainwright - Yahoo Finance

Click here to get full coverage on Chimerix stock soars to 52-week high, hits $5.53 - Investing.com

Chimerix stock soars to 52-week high, hits $5.53  Investing.com

Chimerix stock soars to 52-week high, hits $5.53 - Investing.com

Click here to get full coverage on Jazz Buys Chimerix - A Good Deal To Make With Major Approval Catalyst In Play - Seeking Alpha

Jazz Buys Chimerix - A Good Deal To Make With Major Approval Catalyst In Play  Seeking Alpha

Jazz Buys Chimerix - A Good Deal To Make With Major Approval Catalyst In Play - Seeking Alpha

Click here to get full coverage on Chimerix: Q4 Earnings Snapshot - Norwalk Hour

Chimerix: Q4 Earnings Snapshot  Norwalk Hour

Chimerix: Q4 Earnings Snapshot - Norwalk Hour

Click here to get full coverage on Chimerix stock gains on Jazz Pharma bid (JAZZ:NASDAQ) - Seeking Alpha

Chimerix stock gains on Jazz Pharma bid (JAZZ:NASDAQ)  Seeking Alpha

Chimerix stock gains on Jazz Pharma bid (JAZZ:NASDAQ) - Seeking Alpha

Click here to get full coverage on BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 2seventy bio, Inc. (Nasdaq - TSVT), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Chimerix, Inc. (Nasdaq - CMRX), 180 Degree Capital Corp. (Nasda - GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 2seventy bio, Inc. (Nasdaq - TSVT), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Chimerix, Inc. (Nasdaq - CMRX), 180 Degree Capital Corp. (Nasda  GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 2seventy bio, Inc. (Nasdaq - TSVT), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Chimerix, Inc. (Nasdaq - CMRX), 180 Degree Capital Corp. (Nasda - GlobeNewswire

Click here to get full coverage on Chimerix (CMRX) Announces Updated Phase 2 Response Assessment of Dordaviprone - StreetInsider

Chimerix (CMRX) Announces Updated Phase 2 Response Assessment of Dordaviprone  StreetInsider

Chimerix (CMRX) Announces Updated Phase 2 Response Assessment of Dordaviprone - StreetInsider

Click here to get full coverage on Chimerix Merges with Jazz Pharmaceuticals in $935M Deal - TipRanks

Chimerix Merges with Jazz Pharmaceuticals in $935M Deal  TipRanks

Chimerix Merges with Jazz Pharmaceuticals in $935M Deal - TipRanks

Click here to get full coverage on Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025? - TradingView

Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?  TradingView

Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025? - TradingView

Click here to get full coverage on Durham drug developer Chimerix agrees to sell for $935 million - Business North Carolina

Durham drug developer Chimerix agrees to sell for $935 million  Business North Carolina

Durham drug developer Chimerix agrees to sell for $935 million - Business North Carolina

Click here to get full coverage on Chimerix Pursues FDA Approval for Dordaviprone - TipRanks

Chimerix Pursues FDA Approval for Dordaviprone  TipRanks

Chimerix Pursues FDA Approval for Dordaviprone - TipRanks

Click here to get full coverage on Top 3 Health Care Stocks That May Crash In Q2 - Benzinga

Top 3 Health Care Stocks That May Crash In Q2  Benzinga

Top 3 Health Care Stocks That May Crash In Q2 - Benzinga

Click here to get full coverage on Chimerix’s Strategic Pause and Financial Strength Bolster Long-term Buy Rating Amid Regulatory Milestones - TipRanks

Chimerix’s Strategic Pause and Financial Strength Bolster Long-term Buy Rating Amid Regulatory Milestones  TipRanks

Chimerix’s Strategic Pause and Financial Strength Bolster Long-term Buy Rating Amid Regulatory Milestones - TipRanks

Click here to get full coverage on CHIMERIX INC SEC 10-K Report - TradingView

CHIMERIX INC SEC 10-K Report  TradingView

CHIMERIX INC SEC 10-K Report - TradingView

Click here to get full coverage on Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline - Benzinga

Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline  Benzinga

Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline - Benzinga

Click here to get full coverage on Chimerix Delivers More Than 130% Gain In Less Than 3 Months - RTTNews

Chimerix Delivers More Than 130% Gain In Less Than 3 Months  RTTNews

Chimerix Delivers More Than 130% Gain In Less Than 3 Months - RTTNews

Click here to get full coverage on This MongoDB Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday - Benzinga

This MongoDB Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday  Benzinga

This MongoDB Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday - Benzinga

Click here to get full coverage on SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CMRX, WBA, CKPT on Behalf of Shareholders - The Malaysian Reserve

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CMRX, WBA, CKPT on Behalf of Shareholders  The Malaysian Reserve

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CMRX, WBA, CKPT on Behalf of Shareholders - The Malaysian Reserve

Click here to get full coverage on Chimerix faces Nasdaq delisting over share price woes - Investing.com

Chimerix faces Nasdaq delisting over share price woes  Investing.com

Chimerix faces Nasdaq delisting over share price woes - Investing.com

Click here to get full coverage on Chimerix Soars 220% on FDA Filing Plans for Lifesaving Brain Can - GuruFocus

Chimerix Soars 220% on FDA Filing Plans for Lifesaving Brain Can  GuruFocus

Chimerix Soars 220% on FDA Filing Plans for Lifesaving Brain Can - GuruFocus

Click here to get full coverage on Lightning Could Strike Twice for Biotech Penny Stock Chimerix (NASDAQ:CMRX) - Nasdaq

Lightning Could Strike Twice for Biotech Penny Stock Chimerix (NASDAQ:CMRX)  Nasdaq

Lightning Could Strike Twice for Biotech Penny Stock Chimerix (NASDAQ:CMRX) - Nasdaq

Click here to get full coverage on Chimerix SVP and general counsel sells $7,226 in stock By Investing.com - Investing.com Nigeria

Chimerix SVP and general counsel sells $7,226 in stock By Investing.com  Investing.com Nigeria

Chimerix SVP and general counsel sells $7,226 in stock By Investing.com - Investing.com Nigeria

Click here to get full coverage on Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024 - The Manila Times

Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024  The Manila Times

Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024 - The Manila Times

Click here to get full coverage on CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague. - InvestorPlace

CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.  InvestorPlace

CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague. - InvestorPlace

Click here to get full coverage on CMRX - Chimerix Latest Stock News & Market Updates - Stock Titan

CMRX - Chimerix Latest Stock News & Market Updates  Stock Titan

CMRX - Chimerix Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  The Manila Times

Chimerix Inc (CMRX)

Price Chart

Key Statistics

Technicals

About CMRX

Latest News

Why Chimerix Inc. (CMRX) is Surging in 2025 - Yahoo Finance

CMRX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Chimerix, Inc. is Fair to Shareholders - GlobeNewswire

Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews

Advanced Charts

Top Gainers

Top Losers